--- title: "IDEXX Laboratories to Release 2025 Fourth Quarter and Full Year Financial Results | IDXX Stock News" type: "News" locale: "en" url: "https://longbridge.com/en/news/272111892.md" description: "IDEXX Laboratories, Inc. (NASDAQ: IDXX) will release its 2025 fourth quarter and full year financial results on February 2, 2026, before market opening. An analyst conference call is scheduled for 8:30 a.m. ET that day, accessible via a live webcast and telephone. IDEXX, a leader in pet healthcare innovation, provides diagnostic and software solutions to veterinary practices globally. The company is headquartered in Maine and employs around 11,000 people, serving customers in over 175 countries." datetime: "2026-01-09T10:30:00.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/272111892.md) - [en](https://longbridge.com/en/news/272111892.md) - [zh-HK](https://longbridge.com/zh-HK/news/272111892.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/272111892.md) | [繁體中文](https://longbridge.com/zh-HK/news/272111892.md) # IDEXX Laboratories to Release 2025 Fourth Quarter and Full Year Financial Results | IDXX Stock News WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2025 fourth quarter and full year financial results for Monday, February 2, 2026, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day. Individuals can access a live webcast of the conference call, transcript of prepared remarks, and the Q4 2025 Earnings Snapshot through a link on the IDEXX website, www.idexx.com/investors. An archived edition of the webcast will be available after 1:00 p.m. ET on that day via the same link and will remain available for one year. The live call also will be accessible by telephone. To listen to the live conference call, please dial 1-800-330-6730 or 1-213-279-1575 and reference passcode 263206. **About IDEXX Laboratories, Inc.** IDEXX is a global leader in pet healthcare innovation. Our diagnostic and software products and services create clarity in the complex, constantly evolving world of veterinary medicine. We support longer, fuller lives for pets by delivering insights and solutions that help the veterinary community around the world make confident decisions—to advance medical care, improve efficiency, and build thriving practices. Our innovations also help ensure the safety of milk and water across the world and maintain the health and well-being of people and livestock. IDEXX Laboratories, Inc. is a member of the S&P 500™ Index. Headquartered in Maine, IDEXX employs approximately 11,000 people and offers solutions and products to customers in more than 175 countries and territories. For more information about IDEXX, visit www.idexx.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20260109616999/en/ Investor Relations investorrelations@idexx.com Source: IDEXX Laboratories, Inc. ### Related Stocks - [IDEXX Laboratories, Inc. (IDXX.US)](https://longbridge.com/en/quote/IDXX.US.md) ## Related News & Research - [Idexx Laboratories (IDXX) Valuation Check After New Cancer Dx Panel Launch In The United Kingdom](https://longbridge.com/en/news/281429733.md) - [13:13 ETNapollo Launches VeterinaryMarketing.ai for Veterinary Practices Nationwide](https://longbridge.com/en/news/281405801.md) - [Eastern Bankshares, Inc. Announces First Quarter 2026 Earnings Release Date, Conference Call and Webcast | EBC Stock News](https://longbridge.com/en/news/281540043.md) - [Texas Instruments to webcast Q1 2026 earnings conference call | TXN Stock News](https://longbridge.com/en/news/281395823.md) - [S&T Bancorp, Inc. to Host First Quarter Earnings Conference Call and Webcast | STBA Stock News](https://longbridge.com/en/news/281556643.md)